atovaquone has been researched along with Hepatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forestier, E; Labe, A; Lecomte, C; Raffenot, D; Rogeaux, O | 1 |
| Oz, HS; Tobin, T | 1 |
2 other study(ies) available for atovaquone and Hepatitis
| Article | Year |
|---|---|
[Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
Topics: Antimalarials; Atovaquone; Cerebrospinal Fluid; Cognition Disorders; Confusion; Diagnosis, Differential; Drug Therapy, Combination; Encephalitis, Herpes Simplex; Hepatitis; Humans; Lymphocyte Count; Malaria, Cerebral; Malaria, Falciparum; Male; Meningitis, Aseptic; Middle Aged; Parasitemia; Proguanil; Recurrence; Syndrome | 2011 |
Atovaquone ameliorate gastrointestinal toxoplasmosis complications in a pregnancy model.
Topics: Analysis of Variance; Animals; Anti-Infective Agents; Atovaquone; Disease Models, Animal; Female; Gastrointestinal Tract; Hepatitis; Hyperalgesia; Immunohistochemistry; Mice; Pancreatitis; Pregnancy; Toxoplasmosis, Congenital | 2012 |